These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7094702)

  • 41. Effects of granulocyte-macrophage colony-stimulating factor and interleukin 6 on the growth of leukemic blasts in suspension culture.
    Tsao CJ; Cheng TY; Chang SL; Su WJ; Tseng JY
    Int J Cell Cloning; 1992 May; 10(3):166-72. PubMed ID: 1613267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of responses to therapy and mechanisms of resistance.
    Hall TC
    Semin Oncol; 1977 Jun; 4(2):193-202. PubMed ID: 327553
    [No Abstract]   [Full Text] [Related]  

  • 43. [Mechanism of action of anti-leukemia agents and adverse effects].
    Nakamura T; Ueda T
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1033-9. PubMed ID: 1402252
    [No Abstract]   [Full Text] [Related]  

  • 44. Leukemia revisited.
    Cronkite EP
    Blood Cells; 1981; 7(1):11-30. PubMed ID: 7187744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Oncobiograms and cancer chemotherapy: Hope or reality? (author's transl)].
    Volm M
    Langenbecks Arch Chir; 1975 Nov; 339():121-6. PubMed ID: 1207291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
    Sur P; Nandi N; Ghosh P; Ghosh NC
    Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Autoradiographic in vitro investigations on prostatic tissue with the C-14- und H-3-thymidine double-labeling method (author's transl)].
    Helpap B; Stiens R; Brühl P
    Beitr Pathol; 1974 Jan; 151(1):65-74. PubMed ID: 4131724
    [No Abstract]   [Full Text] [Related]  

  • 48. [Indication for antineoplastic agents (using 3H-thymidine)].
    Fujimoto S; Miyoshi T; Watanabe Y; Watanuki S
    Saishin Igaku; 1971 May; 26(5):997-9. PubMed ID: 5560176
    [No Abstract]   [Full Text] [Related]  

  • 49. The generation time of human leukemic myeloblasts.
    Greenberg ML; Chanana AD; Cronkite EP; Giacomelli G; Schiffer LM; Stryctmans PA; Vincent PC
    Lab Invest; 1972 Mar; 26(3):245-52. PubMed ID: 4502025
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antimitotic chemotherapy and proliferative activity of leukemic cells].
    Astaldi G; Meardi G
    Minerva Med; 1966 Mar; 57(25):1094-6. PubMed ID: 5932009
    [No Abstract]   [Full Text] [Related]  

  • 51. Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors.
    Burke PJ; Karp JE; Braine HG; Vaughan WP
    Cancer Res; 1977 Jul; 37(7 Pt 1):2138-46. PubMed ID: 266416
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pretherapeutical testing of antineoplastic drugs in vitro (author's transl)].
    Projan A; Tanneberger S; Peek U; Nissen E
    Arch Geschwulstforsch; 1982; 52(1):1-7. PubMed ID: 7082128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chemotherapy of acute leukemia].
    Nakamura T; Ueda T
    Rinsho Byori; 1984 Sep; 32(9):967-74. PubMed ID: 6394825
    [No Abstract]   [Full Text] [Related]  

  • 54. Possible mechanism of the selectivity of the cytostatic action of antineoplastic preparations.
    Konradov AA; Levitin EI; Maksimov VM
    Biol Bull Acad Sci USSR; 1979; 6(3):315-8. PubMed ID: 550904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lethal effect of adriamycin on the division cycle of HeLa cells.
    Kim SH; Kim JH
    Cancer Res; 1972 Feb; 32(2):323-5. PubMed ID: 5058189
    [No Abstract]   [Full Text] [Related]  

  • 56. A water-soluble 1,2-diaminocyclohexaneplatinum(II) complex containing procaine hydrochloride: synthesis and antiproliferative activity in vitro.
    Cafaggi S; Esposito M; Parodi B; Viale M
    Pharmazie; 1994 Aug; 49(8):617-8. PubMed ID: 7938154
    [No Abstract]   [Full Text] [Related]  

  • 57. [ACNP therapy for DCMP-resistant acute leukemia (author's transl)].
    Naoe T; Hiraiwa A; Akao Y; Tahara T; Yoshikawa H; Yoshikawa S; Naito K; Yamaguchi H
    Rinsho Ketsueki; 1981 Oct; 22(10):1538-44. PubMed ID: 6460886
    [No Abstract]   [Full Text] [Related]  

  • 58. [Studies of cellular proliferation in infantile leukemia by impulse cytophotometer (I.C.P.) (author's transl)].
    Iwama M
    Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):56-63. PubMed ID: 7264412
    [No Abstract]   [Full Text] [Related]  

  • 59. [Proliferation kinetics of human leukemic blasts, with a special reference to labelling index of 3H-TdR and DNA synthesis time].
    Moteki M
    Nihon Ketsueki Gakkai Zasshi; 1977 Jun; 40(3):284-92. PubMed ID: 270269
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of acute leukemia with 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride (cyclocytidine) (author's transl)].
    Masaoka T; Hasegawa Y; Tatsumi N; Nakamura H; Yoshitake J
    Rinsho Ketsueki; 1973 Aug; 14(8):877-81. PubMed ID: 4797128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.